# Neural and Antidepressant Effects of Propofol

> **NCT03684447** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University of Utah** · enrollment: 48 (estimated)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Propofol
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03684447
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-04-21
- **Primary completion:** 2022-12-31
- **Final completion:** 2024-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03684447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03684447, "Neural and Antidepressant Effects of Propofol". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03684447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*